TY - JOUR
TI - Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension
AU - Cífková, R.
AU - Johnson, M.R.
AU - Kahan, T.
AU - Brguljan, J.
AU - Williams, B.
AU - Coca, A.
AU - Manolis, A.
AU - Thomopoulos, C.
AU - Borghi, C.
AU - Tsioufis, C.
AU - Parati, G.
AU - Sudano, I.
AU - Mcmanus, R.J.
AU - Van Den Born, B.-J.H.
AU - Regitz-Zagrosek, V.
AU - De Simone, G.
JO - EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
PY - 2020
VL - 6
TODO - 6
SP - 384-393
PB - Oxford University Press
SN - null
TODO - 10.1093/ehjcvp/pvz082
TODO - bisoprolol;  corticosteroid;  diuretic agent;  enalapril;  glyceryl trinitrate;  labetalol;  magnesium sulfate;  methyldopa;  metoprolol;  nicardipine;  nifedipine;  urapidil;  antihypertensive agent, Article;  blood pressure measurement;  blood pressure monitoring;  diagnostic test;  disease classification;  disease severity;  eclampsia;  exercise;  fetus lung maturity;  heart failure;  history;  human;  hypertension;  intensive care unit;  maternal hypertension;  obstetric delivery;  perinatal period;  pheochromocytoma;  physical examination;  preeclampsia;  pregnancy;  priority journal;  puerperium;  risk factor;  blood pressure;  consensus;  drug effect;  emergency;  evidence based medicine;  female;  maternal health service;  maternal hypertension;  pathophysiology;  perinatal period;  practice guideline;  severity of illness index;  treatment outcome, Antihypertensive Agents;  Blood Pressure;  Blood Pressure Determination;  Consensus;  Emergencies;  Evidence-Based Medicine;  Female;  Humans;  Hypertension, Pregnancy-Induced;  Maternal Health Services;  Peripartum Period;  Pregnancy;  Risk Factors;  Severity of Illness Index;  Treatment Outcome
TODO - Hypertensive disorders are the most common medical complications in the peripartum period associated with a substantial increase in morbidity and mortality. Hypertension in the peripartum period may be due to the continuation of pre-existing or gestational hypertension, de novo development of pre-eclampsia or it may be also induced by some drugs used for analgesia or suppression of postpartum haemorrhage. Women with severe hypertension and hypertensive emergencies are at high risk of life-threatening complications, therefore, despite the lack of evidence-based data, based on expert opinion, antihypertensive treatment is recommended. Labetalol intravenously and methyldopa orally are then the two most frequently used drugs. Short-acting oral nifedipine is suggested to be used only if other drugs or iv access are not available. Induction of labour is associated with improved maternal outcome and should be advised for women with gestational hypertension or mild pre-eclampsia at 37 weeks' gestation. This position paper provides the first interdisciplinary approach to the management of hypertension in the peripartum period based on the best available evidence and expert consensus. © The Author(s) 2019.
ER -